Technology & AI
New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent
Source: WIRED · Published
The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.
The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.
Related stories
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
Personalized mRNA vaccines against melanoma—the deadliest form of skin cancer—reduced the risk of death or recurrence by 42 percent compared to standard treatment in a late-stage trial, pharmaceutical partners Merck and Moderna announced Thursday . The results are a significant a
Ars Technica - All content ·
Firefighters and public 'knowingly put at risk' during summer wildfires
Crews and control centre staff say the fires were relentless with many firefighters still off work injured.
feeds.bbci.co.uk ·
Lee Chang Dong ponders the ethics of the camera
Lee Chang Dong's seventh feature film, Possible Love, is inspired by true events from 2009, when a Korean conglomerate fired a third of its staff - 2,600 employees - after which many died by suicide. Possible Love is the latest in a long line of Lee movies that engage with themes
The Verge ·
How long is too long for an HDMI cable?
An HDMI cable doesn't have an exact usable length, but shorter is always better for more complex uses.
Engadget - Technology News & Expert Reviews ·
'Father of the PlayStation' Ken Kutaragi sides with Sony on the physical discs debate
The debate about Sony's plan to stop making physical PS5 discs has raged since this summer.
Engadget - Technology News & Expert Reviews ·